Viatris Reports Strong Q2 2026 Results with Revenue Growth and Pipeline Progress#United_States#Pittsburgh#Viatris_Inc.#Gwyn_Lo#Tyrvaya
Viatris Reports Strong Q2 2026 Results with Revenue Growth and Pipeline Progress
Viatris Inc. announces its financial performance for the second quarter of 2026, showcasing significant growth and strategic advancements. The company continues to strengthen its position in the healthcare market.
third-news.com
August 6, 2026 at 11:01 AM
Viatris Reports Strong Q2 2026 Results with Revenue Growth and Pipeline Progress#United_States#Pittsburgh#Viatris_Inc.#Gwyn_Lo#Tyrvaya
Viatris Achieves Milestone with FDA Approval for Groundbreaking Contraceptive Patch#United_States#FDA_Approval#Pittsburgh#Viatris#Gwyn_Lo
Viatris Achieves Milestone with FDA Approval for Groundbreaking Contraceptive Patch
Viatris Inc. announces the FDA's approval of Gwyn Lo™, a revolutionary contraceptive patch designed for women's health, offering low-dose estrogen.
third-news.com
July 29, 2026 at 11:16 AM
Viatris Achieves Milestone with FDA Approval for Groundbreaking Contraceptive Patch#United_States#FDA_Approval#Pittsburgh#Viatris#Gwyn_Lo